Cormorant Global Healthcare Master Fund LP 13D and 13G filings for EyePoint Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-05-01 4:23 pm Purchase | 2023-04-21 | 13G | EyePoint Pharmaceuticals, Inc. EYPT | Cormorant Global Healthcare Master Fund LP | 3,200,000 9.330% | 3,200,000 (New Position) | Filing |